Evidence map›Paper›PMID 26341498›Full record

ArticleInterdisciplinary sciences, computational life sciences2016

Optimization of the Expression Conditions of CGA-N46 in Bacillus subtilis DB1342(p-3N46) by Response Surface Methodology.

Rui-Fang Li, Bin Wang, Shuai Liu, Shi-Hua Chen, Guang-Hai Yu, Shuo-Ye Yang, Liang Huang, Yan-Li Yin, Zhi-Fang Lu

Open access · hybridAbstract read
In one paragraph

Article in Interdisciplinary sciences, computational life sciences, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Inhibition ofBioengineered · 2022
    Article
  3. Article
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Rui-Fang LiCollege of Biological Engineering, Henan University of Technology, Zhengzhou, 450001, China. 1375098398@qq.com.
Bin WangCollege of Biological Engineering, Henan University of Technology, Zhengzhou, 450001, China.
Shuai LiuCollege of Biological Engineering, Henan University of Technology, Zhengzhou, 450001, China.
Shi-Hua ChenCollege of Biological Engineering, Henan University of Technology, Zhengzhou, 450001, China.
Guang-Hai YuCollege of Biological Engineering, Henan University of Technology, Zhengzhou, 450001, China.
Shuo-Ye YangCollege of Biological Engineering, Henan University of Technology, Zhengzhou, 450001, China.
Liang HuangCollege of Biological Engineering, Henan University of Technology, Zhengzhou, 450001, China.
Yan-Li YinCollege of Biological Engineering, Henan University of Technology, Zhengzhou, 450001, China.
Zhi-Fang LuCollege of Biological Engineering, Henan University of Technology, Zhengzhou, 450001, China.
Henan University of Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CGA-N46 is a small antifungal-derived peptide and consists of the 31st-76th amino acids of the N-terminus of human chromogranin A. Polycistronic expression of recombinant CGA-N46 in Bacillus subtilis DB1342 was used to improve its production, but the yield of CGA-N46 was still low. In the present study, response surface methodology (RSM) was used to optimize culture medium composition and growth conditions of the engineered strain B. subtilis DB1342(p-3N46) for the further increase in CGA-N46 yield. The results of two-level factorial experiments indicated that dextrin and tryptone were significant factors affecting CGA-N46 expression. Central composite design (CCD) was used to determine the ideal conditions of each significant factors. From the results of CCD, the optimal medium composition was predicted to be dextrin 16.6 g/L, tryptone 19.2 g/L, KH2PO4·H2O 6 g/L, pH 6.5. And the optimal culture process indicated inoculation of B. subtilis DB1342(p-3N46) seed culture into fresh culture medium at 5 % (v/v), followed by expression of CGA-N46 for 56 hours at 30 °C induced by 2 % (v/v) sucrose after one hour of shaking culture. To test optimal CGA-N46 peptide expression, the yeast growth inhibition assay was employed and it was found that under optimal culture conditions, CGA-N46 inhibited the growth of Candida albican by 42.17, 30.86 % more than that in the pre-optimization conditions. In summary, RSM can be used to optimize expression conditions of CGA-N46 in engineered strains B. subtilis DB1342(p-3N46).

Indexed as

Antifungal AgentsBacillus subtilisBacterial ProteinsBioengineeringBiostatisticsCulture MediaYeastsAntifungal AgentsBacterial ProteinsCulture MediaAntifungal peptideBacillus subtilis engineered strainBiostatistic analysisBiostatistic computer softwareCGA-N46Culture conditions optimizationGenetic engineering expressionResponse surface methodologyTwo-level factorial experiments

Identifiers

PMID26341498
PMCPMC4982894
OpenAlexW2141761148

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.